Intellectual Property
Aug. 27, 2011
Allergan wins patent battle against generic drugmakers
Irvine-based Allergan Inc. won a patent battle against four generic drugmakers in the U.S. District Court for the Eastern District of Texas on Monday.
By Mandy Jackson
Daily Journal Staff Writer
Irvine-based Allergan Inc. won a patent battle in the U.S. District Court for the Eastern District of Texas on Monday when Judge T. John Ward decided that four generic drugmakers' U.S. Food and Drug Administration applications to make and sell generic versions of Combigan infringed four of Allergan's patents for the glaucoma and ocular hypertension drug.
Less than three weeks after a four-day trial that began Aug. 2 in the ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In